Diagnosis and treatment of upper airway oedema caused by acute angio-oedema in the emergency department: a French consensus statement

Archive ouverte

Floccard, Bernard | Javaud, Nicolas | Deroux, Alban | Boccon-Gibod, Isabelle | Fain, Olivier | Amarger, Stéphanie | Blanchard-Delaunay, Claire | Jeandel, Pierre Y. | Marmion, Nicolas | Ollivier, Yann | Pralong, Pauline | Gayet, Stéphane | Du-Thanh, Aurélie | Pelletier, Fabien | Sailler, Laurent | Robinson, Philip | Launay, David | Bouillet, Laurence | (creak), French Reference Centre, For Angioedema

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. Angio-oedema is a transitory, localized, noninflammatory oedema of subcutaneous tissue or mucous. When the oedema affects the mouth, lips, tongue or larynx, it can result in fatal asphyxiation in the absence of specific treatment. Oedema secondary to plasma extravasation is usually mediated by either histamine or bradykinin. As laboratory tests are not available in an emergency setting, the implicated mediator cannot be readily determined. The challenge for the emergency physician is to determine the aetiological type, evaluate severity and initiate adapted treatment by means of a structured approach. A team of experts from the French Reference Centre for Angio-oedema reached a consensus for recommendations for the diagnostic and therapeutic strategy to be adopted by emergency departments faced with angio-oedema of the upper airways in adults. The experts defined 11 important questions. Responses were rated using a two-round Delphi methodology. The 11 recommendations were related to triage on admission, a step-by-step diagnostic protocol, definition of attack severity, discouragement of instrumental examination, prioritization of treatment for severe attacks according to clinical signs and anticipation of access to specific treatments by the hospital. Angio-oedema of the upper airways can be fatal and requires anticipation by the emergency department. A search for the aetiology, an evaluation of clinical symptoms and the availability of the treatments are challenges justifying these recommendations.

Consulter en ligne

Suggestions

Du même auteur

Diagnostic biologique des angioedèmes bradykiniques : les recommandations du CREAK

Archive ouverte | Bouillet, Laurence | CCSD

International audience. Bradykinin mediated angioedema (BK-AE) can be associated either with C1Inhibitor deficiency (hereditary and acquired forms), either with normal C1Inh (hereditary form and drug induced AE as a...

Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs

Archive ouverte | Bouillet, Laurence | CCSD

International audience. Background: Hereditary angioedema (HAE) is characterized by unpredictable and potentially life-threatening attacks of cutaneous and submucosal swelling. Over the past decade, new agents, base...

Efficacy and safety of rituximab-based treatments in angioedema with acquired C1 inhibitor deficiency.

Archive ouverte | Kalmi, Galith | CCSD

International audience. Angioedema (AE) due to acquired C1-inhibitor (C1-INH) deficiency (AAE–C1-INH) is related to excessive consumption of C1-INH or to anti–C1-INH antibodies, and is frequently associated with lym...

Chargement des enrichissements...